- lymphoid neoplasms / IMPC
- hyperplasia / IMPC
- increased blood urea nitrogen level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating LDL cholesterol level / IMPC
- increased circulating fructosamine level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral density / IMPC
- neoplasm / IMPC
C57BL/6NTac-Setd1atm1c(EUCOMM)Wtsi/H
| Status | Available to order |
| EMMA ID | EM:15687 |
| Citation information | RRID:IMSR_EM:15687 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6NTac-Setd1atm1c(EUCOMM)Wtsi/H |
| Alternative name | C57BL/6NTac-Setd1a |
| Strain type | Targeted Mutant Strains : Conditional mutation |
| Allele/Transgene symbol | Setd1atm1c(EUCOMM)Wtsi |
| Gene/Transgene symbol | Setd1a |
Information from provider
| Provider | MRC, Medical Research Council |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | The L1L2_gt0 cassette was inserted at position 127379089 of Chromosome 7 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT flanked lacZ/neomycin sequence followed by a loxP site. An additional loxP site is inserted downstream of the targeted exon(s) at position 127380049. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele to remove the lacZ sequence and neo selection cassette, leaving loxP sites flanking the critical exon(s). The tm1c allele was generated using Flp recombinase to excise the lacZ-neomycin cassette present in the tm1a allele. The tm1c allele still carries loxP sites available for excision by cre recombinase. |
| Phenotypic information | Homozygous:No abnormal phenotype reportedHeterozygous:No abnormal phenotype reported |
| References |
|
| Homozygous fertile | not known |
| Homozygous viable | not known |
| Homozygous matings required | not known |
| Immunocompromised | not known |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased leukocyte cell number / MGI
- failure to gastrulate / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased rib number / MGI
- decreased circulating cholesterol level / MGI
- cellular phenotype / MGI
- abnormal cell physiology / MGI
- abnormal DNA methylation / MGI
- decreased total body fat amount / MGI
- embryonic lethality between implantation and somite formation, complete penetrance / MGI
Literature references
- Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement.;Tusi Betsabeh Khoramian, Deng Changwang, Salz Tal, Zeumer Leilani, Li Yangqiu, So Chi Wai Eric, Morel Laurence M, Qiu Yi, Huang Suming, ;2015;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;29;1505-15; 25550471
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
